Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sanuwave Health Inc (OP: SNWV )

0.0220 UNCHANGED
Streaming Delayed Price Updated: 3:51 PM EDT, May 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0220
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0220
Today's Range 0.0220 - 0.0220
52wk Range 0.0046 - 0.0298
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
SANUWAVE Announces Q1 FY2024 Financial Results
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
SANUWAVE Announces Q1 FY2024 Financial Results
Q1 2024 revenues were $5.8 million, up 53% from Q1 2023 
Via TheNewswire.com

Performance

YTD
+22.22%
+22.22%
1 Month
+10.00%
+10.00%
3 Month
-4.35%
-4.35%
6 Month
+47.65%
+47.65%
1 Year
+12.82%
+12.82%

More News

Read More
SANUWAVE Will Host a Conference Call on May 10, 2024 at 8:30 AM (ET) to Present Q1 Financial Results
Via NewMediaWire
SANUWAVE Will Host a Conference Call on May 10, 2024 at 8:30 AM (ET) to Present Q1 Financial Results
Via TheNewswire.com
SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024)
Via NewMediaWire
SANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial Officer
Via NewMediaWire
SNWV Stock Earnings: SANUWAVE Health Reported Results for Q4 2023
Via InvestorPlace
SANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial Officer
Via TheNewswire.com
SANUWAVE Announces Record Q4 and FY2023 Revenue
Via NewMediaWire
SANUWAVE Will Host a Conference Call on March 22, 2024 at 8:30 AM (ET) to Present the Q4 and FY2023 Financial Results
Via NewMediaWire
SANUWAVE Health Reports Stockholder Approval of SEPA Merger at Special Meeting of Stockholders
Via NewMediaWire
SANUWAVE Health Reports Stockholder Approval of SEPA Merger at Special Meeting of Stockholders
Via TheNewswire.com
SANUWAVE Announces Special Meeting of Stockholders to Vote on Business Combination with SEP Acquisition Corp. (Nasdaq: SEPA)
Via NewMediaWire
SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2023, Ended December 31, 2023
Via NewMediaWire
SANUWAVE Announces Q3 2023 Financial Results
Via NewMediaWire
SANUWAVE Will Host a Conference Call on November 10, 2023 at 8:00 AM (ET) to Present the Q3 2023 Financial Results
Via NewMediaWire
SANUWAVE Health Announces Preliminary Revenue Results for the Third Quarter Ended September 30, 2023
Via NewMediaWire
SANUWAVE Health, Inc., a Leading Provider of FDA Approved Next-Generation Wound Care Products, Enters into a Merger Agreement with Sweat Equity Partners and Mercury Life Sciences-affiliated SEP Acquisition Corp., a Nasdaq-Listed Company
Via NewMediaWire
Exposures Product Safety
SANUWAVE Announces Q2 2023 Financial Results
Via NewMediaWire
SANUWAVE Will Host a Live Conference Call on August 11, 2023 at 8:30 AM (EDT) to Present Its Q2 2023 Financial Results
Via NewMediaWire
SANUWAVE Signs Distribution Agreement With Pacific Medical, Inc.
Via NewMediaWire
SANUWAVE Health Appoints Industry Veteran Andrew Walko as President
Via NewMediaWire
Topics Economy
Exposures Supply Chain
SANUWAVE Health Announces Preliminary Revenue Results for the Second Quarter Ended June 30, 2023
Via NewMediaWire
SANUWAVE Health, Inc. Appoints Morgan Frank as Chief Executive Officer
Via NewMediaWire
SANUWAVE Announces Q1 2023 Financial Results
Via NewMediaWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.